Ultrasonography in the Diagnosis of Nasal Fractures

December 8, 2023 updated by: Grzegorz Śmigielski, Medical University of Gdansk

High-resolution Point of Care Ultrasonography in the Diagnosis of Nasal Fractures: a 10-step Protocol

The purpose of this cross-sectional prospective observational study is to determine the efficacy of high-resolution ultrasonography in identifying and characterizing nasal bone fractures in adult patients with recent facial trauma. The primary questions it aims to answer are:

  • Can high-resolution ultrasonography effectively detect nasal bone fractures?
  • Is high-resolution ultrasonography capable of indirectly detecting septal fractures?
  • What are the specificity and sensitivity of high-resolution ultrasonography in comparison to computed tomography scan?

Participants will undergo examination and treatment in accordance with current standards for nasal fracture management. Additionally, high-resolution ultrasonography will be performed during the initial physical examination, preceding any therapeutic interventions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

BACKGROUND

The bony and cartilaginous skeleton of the external nose is exceptionally prone to injury, due to its fragile structure and protruding, tent-like shape. As the cartilages are able to bend under pressure, the impact of trauma is usually transferred to the thinnest, distal parts of nasal bones, where they overlap the lateral cartilages forming a junction called the keystone region. This location plays a major role in supporting the cartilaginous skeleton and, at the same time, is most likely to be fractured. Similarly, the cartilaginous nasal septum is able to bend, which is the reason why trauma to the distal nasal bones frequently continues along anterior borders of the perpendicular plate of the ethmoid and vomer, creating a complex, C-shaped septal fracture. These pathomechanisms of nasal fracture explain its possible significant negative influence on the function and aesthetics of the nose. Early nasal fracture detection and treatment is critical for avoiding complications. Clinical examination is considered a gold standard for the diagnosis. Imaging tests are of secondary importance, as their clinical application in this condition has many disadvantages. A commonly applied plain radiograph of the nose was proven not to be cost efficient due to high percentage of false results. A computed tomography scan (CT) has a satisfactory sensitivity and specificity, but is relatively expensive, causes radiation exposure and provides images of limited resolution, which may fail to reveal subtle fracture lines.

Several studies have shown high-resolution ultrasonography (HRUS) to be a safe and efficient method for nasal fracture diagnosis. However, the use of this modality in a clinical setup has not become common, despite over 20-year history of publications supporting its efficacy. Potential factors contributing to this circumstance include a lack of a standardized examination protocol, a difficult ultrasonography image acquisition and a clinician's reluctance to use a full-sized device in an otolaryngology medical office.

The aim of this study is to assess the efficacy of a standardized 10-step point-of-care ultrasonography in the diagnosis of nasal fractures.

STUDY DESIGN

This cross-sectional prospective study will be conducted between December 1, 2023, and December 1, 2024, at the University Clinical Centre in Gdańsk, in accordance with the Helsinki Declaration and with approval from the institutional bioethics committee for scientific research (No: KB/625/2023).

Patients who have presented to the emergency department with nasal trauma sustained within the 14 days preceding their consultation will be enrolled in the study. Exclusion criteria will include extensive facial trauma, a history of nasal fracture, surgical interventions (e.g. rhinoplasty, frontal/ethmoid sinus surgery), or minor invasive procedures (e.g. hyaluronic acid filler, thread lifting) in the examined area.

A CT scan of the face and HRUS protocol will be performed before any interventions are undertaken.

A total of 50 patients is anticipated.

The collected data will include medical history, physical examination, CT scan of the face and HRUS of the nose.

Ultrasonography of the external nose will be performed with the use of a high-resolution transducer (Clarius L20HD3 8-20 MHz) and a 3mm-thick disposable gel pad, according to the 10-step protocol. At each location, the transducer position will be adjusted with rocking and tilting movements until it is held perpendicular to the bone surface, which provides optimal image quality, and a single image will be saved for further assessment. Images obtained at each location will be assessed for five different findings.

A standard computed tomography scan of the face will be performed. Each of 7 specific areas will be assessed by an experienced radiologist for a diclocated or non-dislocated nasal fracture.

DATA ANALYSIS

Statistical analysis of the data will be performed using the R language. A variable marked as a "final diagnosis established by the consulting clinician" will be considered a reference point for calculating the sensitivity and specificity of methods. For this purpose, a McNeymar chi-square test and Cohen's Kappa will be used.

Records lacking the final diagnosis or any part of the HRUS protocol will be excluded from the study.

The database will be anonymised.

The source data and the database verification will be performed collectively by the authors following the addition of every 10 new records.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Poland
    • Pomorskie
      • Gdańsk, Pomorskie, Poland, 80-210
        • Recruiting
        • Medical University of Gdansk
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Karolina Markiet, Ph.D.
        • Sub-Investigator:
          • Bogusław Mikaszewski, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients with a history of recent facial trauma involving external nose. Patients with no history of surgical or non-surgical interventions in the examined area eg. rhinoplasty, hyaluronic acid filler, external approach frontal/ethmoid sinus surgery as well as no history of nasal fracture.

Description

Inclusion Criteria:

  • nasal trauma during the 14 days preceding examination

Exclusion Criteria:

  • extensive facial injuries
  • history of surgical or non-surgical interventions in the examined area
  • history of nasal fracture
  • refusal to participate, inability to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Suspected nasal fracture
Patients with a history of recent nasal trauma.
Diagnostic test: Nasal Ultrasonography

Ultrasonography of the external nose will be performed with the use of a high-resolution transducer (Clarius L20HD3 8-20 MHz) and a 3mm-thick disposable gel pad, according to the following protocol:

  1. Sagittal plane, along the most prominent part of nasal dorsum.
  2. Transverse plane, level of nasion.
  3. Transverse plane, level of intercanthal line.
  4. Transverse plane, level of rhinion.
  5. Along inferior border of the right nasal bone.
  6. Along inferior border of the left nasal bone.
  7. Along medial part of the right orbital rim below frontomaxillary suture.
  8. Along medial part of the right orbital rim below frontomaxillary suture.
  9. Along the line connecting right frontomaxillary suture and the tip of the nose.
  10. Along the line connecting left frontomaxillary suture and the tip of the nose.

At each location the transducer position will be adjusted until it is held perpendicular to the bone surface and a single image will be saved for further assessment.

Other Names:
  • High resolution 10-point ultrasonography of the external nose.
Diagnostic test: Computed Tomography Scan of the Face

A standard computed tomography scan of the face will be performed and the following areas will be assessed by an experienced radiologist:

  1. Bony part of the nasal septum
  2. Left nasal bone - part proximal to the intercanthal line
  3. Right nasal bone - part proximal to the intercanthal line
  4. Left nasal bone - part distal to the intercanthal line
  5. Right nasal bone - part distal to the intercanthal line
  6. Frontal process of the left maxilla
  7. Frontal process of the right maxilla
Other Names:
  • A computed tomography covering the whole facial skeleton and a skull base.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nasal Ultrasonography: a 10-step protocol.
Time Frame: Each participant will be assessed once, within 14 days of the nasal trauma.

Images obtained at each location will be assessed for the following five findings:

  1. isolated bone discontinuity
  2. misalignment of the bone surface without displaced fracture edges
  3. misalignment of the bone surface with displaced fracture edges
  4. dislocated minor bone fragment (largest dimension under 2 mm)
  5. soft tissue haematoma

There will be 50 variables in total, marked as a combination of location (number 1-10) and finding (a-e) e.g. 1a, 1b, 1c, 1d, 1e, 2a, 2b, 2c ,2d.

Variables will be dichotomous, with possible values of P (positive), N (negative) and N/A (not to be assessed).
Each participant will be assessed once, within 14 days of the nasal trauma.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Computed Tomography of the Face
Time Frame: Each participant will be assessed once, within 14 days of the nasal trauma.

Each of 7 anatomical areas will be assessed for one of two findings:

  1. non-displaced fracture
  2. displaced fracture

There will be 14 variables in total, marked as a combination of location (number 1-7) and finding (a-b) e.g. 1a, 1b, 2a, 2b, 3a, 3b.

Variables will be dichotomous, with possible values of P (positive), N (negative) and N/A (not to be assessed).
Each participant will be assessed once, within 14 days of the nasal trauma.
Clinical features
Time Frame: Each participant will be assessed once, within 14 days of the nasal trauma.

Following clinical data associated with present nasal trauma will be collected and entered into the database as variables:

  • time period since the injury
  • epistaxis
  • nasal obstruction
  • crepitus or palpable mobility of bone fragments
  • swelling of the nasal pyramid
  • nasal pyramid asymmetry - absent before trauma
  • septal deviation - absent before trauma
  • fracture reposition attempt
  • improvement after reposition

Variables will be dichotomous, with possible values of P (positive), N (negative) and N/A (not to be assessed), except for time period, which will be a number in the range from 0 to 14.
Each participant will be assessed once, within 14 days of the nasal trauma.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Gdansk

Investigators

  • Principal Investigator: Grzegorz Śmigielski, M.D., Medical University of Gdansk

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 29, 2023

First Submitted That Met QC Criteria

December 6, 2023

First Posted (Actual)

December 8, 2023

Study Record Updates

Last Update Posted (Estimated)

December 11, 2023

Last Update Submitted That Met QC Criteria

December 8, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NFUS2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study Protocol and Statistical Analysis Plan will be shared upon request, including individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Proposals should be directed to "g.smigielski@gumed.edu.pl". To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Time Frame

Beginning 6 months and ending 36 months following article publication.

IPD Sharing Access Criteria

For individual participant data meta-analysis. Proposed use of the data should have been approved by an independent review committee.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Facial Injuries

Clinical Trials on Nasal Ultrasonography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe